Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,238 | -81,568 | -31,829 | -67,851 | -45,741 |
| Depreciation Amortization | 13,098 | 8,174 | 3,884 | 9,101 | 6,010 |
| Income taxes - deferred | N/A | N/A | N/A | -1,597 | -1,235 |
| Accounts receivable | 11,581 | 6,894 | -179 | -7,389 | 908 |
| Accounts payable and accrued liabilities | 846 | -2,476 | 9,491 | 4,341 | 426 |
| Other Working Capital | -11,700 | -7,083 | -1,537 | -8,303 | 9,757 |
| Other Operating Activity | 94,709 | 39,412 | 6,888 | 24,564 | 13,083 |
| Operating Cash Flow | $-44,704 | $-36,647 | $-13,282 | $-47,134 | $-16,792 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -272,624 | -267,754 | 48,288 | -288,957 | -319,404 |
| PPE Investments | -28,891 | -19,105 | -9,598 | -18,717 | -11,628 |
| Net Acquisitions | N/A | N/A | N/A | -7,328 | -7,328 |
| Purchase Sale Intangibles | -17,886 | -17,886 | -17,886 | -2,500 | -2,568 |
| Other Investing Activity | -17,886 | -17,886 | -17,886 | -2,568 | -2,568 |
| Investing Cash Flow | $-319,401 | $-304,745 | $20,804 | $-317,570 | $-340,928 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -125 | -79 | -38 | -127 | -79 |
| Common Stock Issued | 367,085 | 363,234 | 1,504 | 368,465 | 365,345 |
| Other Financing Activity | -3,377 | -369 | 0 | -1,034 | -1,039 |
| Financing Cash Flow | $363,583 | $362,786 | $1,466 | $367,304 | $364,227 |
| Exchange Rate Effect | 239 | 49 | 23 | 84 | 137 |
| Beginning Cash Position | 143,228 | 143,228 | 143,228 | 140,544 | 140,544 |
| End Cash Position | 142,945 | 164,671 | 152,239 | 143,228 | 147,188 |
| Net Cash Flow | $-283 | $21,443 | $9,011 | $2,684 | $6,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,704 | -36,647 | -13,282 | -47,134 | -16,792 |
| Capital Expenditure | -28,891 | -19,105 | -9,598 | -18,717 | -11,628 |
| Free Cash Flow | -73,595 | -55,752 | -22,880 | -65,851 | -28,420 |